Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 23CNS 23Thoracic 17Genitourinary 17Sarcoma 15Head & Neck 9Other solid neoplasm 6Breast 6Lymphoid 3Endocrine 3Gynecologic 2Tumor-Agnostic 1Plasma cell 1Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 2Radiation Injuries 1

Interventions

Paclitaxel 575Carboplatin 520Cisplatin 347Bevacizumab 252pembrolizumab 226Gemcitabine 157Topotecan 128liposomal doxorubicin 127Cyclophosphamide 126olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 80niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 56Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Proton Therapy × Gynecologic × Clear all
NCT06462378 2024-06-17

Proton Therapy for Locally Advanced Cervical Cancer

University of Aarhus

Phase 2 Recruiting
55 enrolled
Gynecologic

Uterine Cervical Neoplasms, Radiation Injuries

NCT01019278 2020-04-03

Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes

Abramson Cancer Center at Penn Medicine

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡